Skip to content

Brought to you by

Dentons logo in black and white

Dentons Canada Regulatory Review

The latest information and developments on regulatory law across Canada.

open menu close menu

Dentons Canada Regulatory Review

  • Home
  • About Us
  • Dentons COVID-19 hub

Health Canada is watching! Businesses marketing products with anti-microbial claims should proceed with care

By Monica Song and Yulia Konarski
July 12, 2021
  • Health
  • Product Regulation
  • Regulatory
Share on Facebook Share on Twitter Share via email Share on LinkedIn

For many businesses, the COVID-19 pandemic saw the advent of new sources of demand for sanitizing products for personal use or in public environments, stimulating the growth of anti-microbial claims being made in relation to existing products or the development of new products making such claims. From UV disinfecting wands and air filters for the home to disinfecting sprays for high-touch surfaces in public spaces, the demand is there and the market looks to be here to stay.

From a business perspective, widely advertising any and all anti-microbial properties a product may have to capitalize on the market potential of these types of products makes perfect sense.   However, improper anti-microbial claims may trigger compliance issues for your business.   Among other issues, consumer products generally and health products in particular are classified based upon how the product is “manufactured, sold or represented for use.” An anti-microbial claim, e.g., “useful against COVID-19” or “kills 99% of bacteria” may affect the regulatory classification of a product.  In turn, the re-classification of a product may trigger a host of regulatory requirements, such as product approval, registration, labelling, site licencing etc.  Where non-compliance is found, enforcement can include stop-sale or recall requirements until the claim is removed from the marketplace or the product is otherwise brought into compliance.

Health Canada is on high alert for products claiming to be effective against COVID-19 or more generally against any virus, bacteria, irritants, disease and the like and the regulatory landscape for these products is in rapid flux. The lines between different regulatory regimes have blurred, bringing to the fore novel questions of interpretation and application. Some examples of recent developments include:

  • At the start of the pandemic, Health Canada issued an advisory regarding false or misleading claims to prevent, treat or cure COVID-19. Health Canada clearly signalled its intent to monitor all such claims, stating, “selling or advertising health products that make false or misleading claims is illegal. The Department takes this issue seriously and will not hesitate to use all mechanisms and tools at its disposal to stop these activities.” This increased monitoring of products making inappropriate anti-microbial claims is expected to extend to general anti-microbial claims.
  • In March of this year, the Pest Management Regulatory Agency (PMRA) of Health Canada issued an information note that “treated articles”, i.e. consumer goods or goods sold business to business that claim to have anti-microbial properties based on the incorporation of a pest control agent in the good, may be themselves considered pest control products requiring registration under the Pest Control Products Act (PCPA).
  • In June, the Interim order regulating certain UV radiation-emitting and ozone-generating devices under the Pest Control Products Act (June IO) came into effect. The June IO clarifies that certain ultraviolet radiation-emitting devices and ozone-generating devices claiming to kill bacteria and viruses are pest control products subject to the regulatory requirements of the PCPA, including the requirement to register and additional labelling requirements.
  • By contrast, devices including UV wands and air filters, which make claims beyond simply killing microbes but also claim to prevent infection with COVID-19 or other illnesses are exempt from application of the June IO, but may be regulated as a medical device.

Judging from the rapid pace at which Health Canada is issuing iterative guidance and passing new legislation that introduces new regulatory requirements for products making these claims, Health Canada is clearly on the alert for products making anti-microbial claims. 

One thing is certain in this evolving regulatory landscape: there is a high risk Health Canada will detect products making anti-microbial claims that may be non-compliant with one or more regulatory regimes triggered by the anti-microbial claim – be it for pest control products, medical devices, drugs or natural health products.

Please contact Monica Song or Yulia Konarski if you have any questions about how your product may be regulated in Canada.

Share on Facebook Share on Twitter Share via email Share on LinkedIn
Subscribe and stay updated
Receive our latest blog posts by email.
Stay in Touch
Monica Song

About Monica Song

Monica Song is the national co-leader of Dentons Canada’s Regulatory group. Monica is a senior administrative and public policy lawyer with a deep understanding of the Canadian legislative and public policy landscape who specializes in advising clients spearheading growth and innovation in the digital economy.

All posts Full bio

Yulia Konarski

About Yulia Konarski

Yulia Konarski is an associate in our Regulatory group with a practice that focuses on regulated products under the Food and Drugs Act, including food, drugs, natural health products, cosmetics and medical devices. Yulia regularly advises clients about their obligations in relation to importing and selling these products into Canada.

All posts Full bio

RELATED POSTS

  • Administrative Law
  • Environmental
  • Regulatory

It pays to be green: Ontario to expand administrative penalties for environmental contraventions

By Dina Awad and Kate Wiltse | March 18, 2022
  • Health
  • Marketing/Advertising
  • Product Regulation
  • Regulatory

The next step to a healthier Canada: Legislation proposing to ban advertising “unhealthy” food and beverages directed at children

By Monica Song and Yulia Konarski | November 23, 2022
  • Regulatory

R. v. Mossman: British Columbia Court of Appeal holds that knowledge or intent is not required to impose secondary liability for environmental offences

By Dina Awad and Janson Fu | March 31, 2026

About Dentons

Redefining possibilities. Together, everywhere. For more information visit dentons.com

Grow, Protect, Operate, Finance. Dentons, the law firm of the future is here. Copyright 2023 Dentons. Dentons is a global legal practice providing client services worldwide through its member firms and affiliates. Please see dentons.com for Legal notices.

Check out more at Dentons.com

Disclosure in mining

Canada: This first article examines how the Bre-X scandal led to the creation of NI 43-101, which now governs disclosure standards for the Canadian mining industry. NI 43-101 aims to protect [...]

Ontario's Data Centre Playbook: New rules for a new era of electricity demand

Data centres are the physical infrastructure behind the digital economy: every email, online transaction and artificial intelligence (AI) query depends on a warehouse-scale facility requiring a continuous, high-volume supply of [...]

CSA 2025–2026 Year in Review: What market participants need to know

The Canadian Securities Administrators (CSA) has released its Year in Review for the period July 1, 2025 to June 30, 2026, summarizing progress under its 2025-2028 Business Plan. [...]

Categories

Dentons logo in black and white

© 2026 Dentons

  • Legal notices
  • Privacy policy
  • Terms of use
  • Cookies on this site